Major clinical response to a BRAF inhibitor in a patient with a BRAF L597R-mutated melanoma.
about
CIViC databaseTargeted Therapies in Non-Small Cell Lung Cancer-Beyond EGFR and ALKBeyond histology: translating tumor genotypes into clinically effective targeted therapies.Enabling a genetically informed approach to cancer medicine: a retrospective evaluation of the impact of comprehensive tumor profiling using a targeted next-generation sequencing panelTongue carcinoma infrequently harbor common actionable genetic alterationsThe combinatorial complexity of cancer precision medicine.Clinical detection and categorization of uncommon and concomitant mutations involving BRAF.Integrative molecular profiling of routine clinical prostate cancer specimens.Comparison between two widely used laboratory methods in BRAF V600 mutation detection in a large cohort of clinical samples of cutaneous melanoma metastases to the lymph nodes.Radiation therapy for advanced and metastatic melanoma.Alterations in genes other than EGFR/ALK/ROS1 in non-small cell lung cancer: trials and treatment options.Beyond the BRAFV600E hotspot: biology and clinical implications of rare BRAF gene mutations in melanoma patients.CD271 is an imperfect marker for melanoma initiating cells.Clinicopathological features and clinical outcomes associated with TP53 and BRAFNon-V600 mutations in cutaneous melanoma patients.Clinical application of a cancer genomic profiling assay to guide precision medicine decisions.Cooperation of BRAF(F595L) and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signaling.Anaplastic Transformation of Papillary Thyroid Carcinoma in a Young Man: A Case Study with Immunohistochemical and BRAF Analysis.Detection of EGFR and BRAF mutations by competitive allele-specific TaqMan polymerase chain reaction in lung adenocarcinoma.[Response of BRAF(L597Q)-mutant melanoma to trametinib : Targeted melanoma therapy beyond BRAF(V600) mutations].Discordancy in BRAF mutations among primary and metastatic melanoma lesions: clinical implications for targeted therapy.
P2860
Q27612411-8A82EB7B-76B3-4074-97C8-139FD4C77F1FQ28083446-21FBC416-9316-4283-BEEF-1E7889F1380CQ33560928-90F3D7B5-0449-4AE5-916D-E3ACAFCC1CC5Q33699641-8FB9E012-C333-49B8-AFD7-796188B4E9AAQ34256064-B66FED54-21B7-43A0-9EA8-CEA01ECC087DQ34781332-DFAE62EB-6B9C-4CF0-8BE5-8D87185E7006Q35820044-30CFFFED-BCB8-4F6A-B85E-B11C179893F0Q35892022-1EF8684E-0B2F-4D3D-9B85-3DA9B9A99EC0Q36014476-7C78C599-C9A8-4806-B30E-E2E27FC3C78BQ38166905-99E25997-1FFB-41DB-B0EA-7C25B3BB8F39Q38825099-C3C9EEA4-032B-4ABE-9542-F0C14F2D42A3Q38917480-AFAA51EF-B8A6-459F-91F8-C778EA0037EBQ38967844-260638CE-A638-4F2B-8945-0D79DA899189Q39135886-CC6639A5-67FE-40CB-AA97-C2A5B4439515Q40048521-F89943B3-BE6E-46D0-88E1-01F57EB2B2DEQ40305624-32D2C1B3-B5D3-43E3-81BA-A074AE3076D2Q42725637-B1FFA2AB-27AD-4AB9-90E5-0BE539C19B5BQ50192132-5C7A68E3-586D-4650-A1D3-101AEE25D65EQ53787043-D77007E8-AF3D-49DC-B1B6-FAF2ADA72049Q54311181-3ADB837C-0BF9-4EB5-87B6-8082C50E66FD
P2860
Major clinical response to a BRAF inhibitor in a patient with a BRAF L597R-mutated melanoma.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Major clinical response to a B ...... a BRAF L597R-mutated melanoma.
@ast
Major clinical response to a B ...... a BRAF L597R-mutated melanoma.
@en
Major clinical response to a B ...... a BRAF L597R-mutated melanoma.
@nl
type
label
Major clinical response to a B ...... a BRAF L597R-mutated melanoma.
@ast
Major clinical response to a B ...... a BRAF L597R-mutated melanoma.
@en
Major clinical response to a B ...... a BRAF L597R-mutated melanoma.
@nl
prefLabel
Major clinical response to a B ...... a BRAF L597R-mutated melanoma.
@ast
Major clinical response to a B ...... a BRAF L597R-mutated melanoma.
@en
Major clinical response to a B ...... a BRAF L597R-mutated melanoma.
@nl
P2093
P50
P356
P1476
Major clinical response to a B ...... a BRAF L597R-mutated melanoma.
@en
P2093
Damien Giacchero
Elodie Long-Mira
Florence Le Duff
Maryline Allegra
P304
P356
10.1200/JCO.2012.46.1061
P407
P577
2013-07-01T00:00:00Z